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Abstract
Herpesviruses are DNA viruses harboring the capacity to establish lifelong latent-recurrent 
infections. There is currently limited knowledge on viruses targeting the innate DNA sensing 
pathway and also on how the innate system impacts on the latent reservoir of herpesvirus 
infections. Here we report that murine gammaherpesvirus MHV68, in contrast to alpha- and beta-
herpesviruses, induce very limited innate immune responses through DNA-stimulated pathways, 
which correspondingly played only a minor role in control of MHV68 infections in vivo. 
Similarly, Kaposi's sarcoma-associated herpesvirus also did not stimulate immune signaling 
through the DNA sensing pathways. Interestingly, a MHV68 mutant lacking the deubiquitinase 
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(DUB) activity, embedded within the large tegument protein ORF64, gained the capacity to 
stimulate the DNA-activated STING pathway. We found that ORF64 targeted a step in the DNA-
activated pathways upstream of the bifurcation into the STING and AIM2 pathways, and lack of 
the ORF64 DUB was associated with impaired delivery of viral DNA to the nucleus, which 
instead localized to the cytoplasm. Correspondingly, the ORF64 DUB active site mutant virus 
exhibited impaired ability to establish latent infection in wild type but not STING-deficient mice. 
Thus, gammaherpesviruses evade immune activation by the cytosolic DNA sensing pathway, 
which in the MHV68 model facilitates establishment of infections.
Introduction
Herpesviruses are capable of establishing latent-recurrent infections, and can give rise to 
disease in both the acute and recurrent phase, mainly in immuno-suppressed individuals. 
Herpesviruses are DNA viruses that enter cells through the plasma membrane or an 
endosomal route and shuttle through the cytoplasm for delivery of DNA to the nucleus 
where productive replication takes place (1). Three sub-classes of herpesviruses exist, 
termed alpha-, beta-, and gamma-herpesviruses, which have a common set of properties as 
well as functions specific for the different subfamilies. Advances in the field of innate 
immunology have revealed important roles for the innate immune system in host control of 
herpesvirus infections (2-4). In corroboration with this notion, knowledge on herpesviruses 
evading innate immune responses are now starting to emerge (5), but information on how 
this impacts on establishment of acute and latent infections is still lacking. Therefore, in this 
study we hypothesized that herpesviruses target key elements of the innate immune system 
with the purpose of facilitating establishment of latent infection.
Nucleic acids are believed to be the main inducers of innate immunity during viral infection 
(6), with type I IFN production and inflammasome-dependent IL-1β maturation being two 
important biological responses evoked by these viral molecules. For herpesviruses it is 
known that viral RNA and DNA are detected by endosomal TLRs as well as cytoplasmic 
RNA sensors (3,7-9). Recently, much focus has been given towards intracellular DNA, and 
it is now emerging that viral DNA in the cytoplasm and the nucleus can also trigger the 
innate immune system (4,10-15). In vivo studies have revealed important roles for DNA 
sensing pathways in host protection against herpesvirus infections (2,4). Common to the 
IFN-stimulating pathways triggered by intracellular DNA is the requirement for Stimulator 
of IFN genes (STING) (2). STING is a tetra-membrane-spanning endoplasmic reticulum 
protein, which translocates to specific vesicular structures after DNA recognition, where 
signaling is believed to take place (2). Cytosolic DNA also stimulates inflammasome 
activation through a pathway dependent on absent in melanoma 2 (AIM2), and in this 
manner leads to assembly of a caspase 1-containing complex capable of cleaving pro-IL-1β 
and pro-IL-18 into the biologically active forms (16).
We recently demonstrated that genomic DNA of alpha-herpesviruses (HSV) and beta-
herpesvirues (cytomegalovirus (CMV)) is detected by DNA sensors in the cytosol after 
degradation of the capsid (17). Detection of HSV and CMV DNA has been reported to 
involve the DNA sensors IFN inducible protein (IFI) 16 and cyclic-GMP-AMP (cGAMP) 
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synthetase (cGAS), the latter stimulating cGAMP-mediated STING-dependent signaling and 
induction of type I IFN expression (15,17). It is also documented that CMV stimulates 
inflammasome activation in a manner dependent on AIM2 (4). The subfamily of 
gammaherpesviruses includes the human pathogenic viruses Epstein-Barr virus (EBV) and 
Kaposi's sarcoma-associated herpesvirus (KSHV), and the murine gammaherpesvirus 68 
(MHV68). All these viruses are detected by TLR9 in plasmacytoid dendritic cells (9,18,19), 
and it has been reported that IFI16 detects KSHV DNA in the nucleus in endothelial cells to 
induce caspase 1 activation and pro-IL-1β maturation (14). However, despite the importance 
of STING and AIM2 in the response to alpha- and beta-herpesvirus infections, there is 
limited information on the role of the DNA-activated pathways in innate responses to 
gammaherpesvirus infections. Moreover, information on the impact of innate immune 
activation on the establishment of the latent reservoir of herpesvirus infections is still sparse.
In this work we report that the gammaherpesviruses MHV68 and KSHV, in contrast to 
alpha- and beta-herpesviruses, only weakly induce innate immune responses through DNA-
stimulated pathways. We identified that an ORF64 deubiquitinase (DUB)-deficient MHV68 
mutant gained the capacity to induce type I interferon through the DNA-activated STING 
pathway, hence suggesting an essential role for the DUB in evading host immune activation. 
Importantly, the MHV68 ORF64 mutant virus exhibited impaired ability to establish latent 
infection in wild type but not in STING-deficient mice. Collectively, these data suggest that 
gammaherpesviruses evade immune activation by the cytosolic DNA sensing pathway via 
the DUB activity embedded in the viral tegument and that this contributes to the ability of 
these viruses to establish latent infections.
Materials and Methods
Mice
For this study we used C57BL/6, TLR3-/-, TLR2/9-/-, STINGgt/gt, ASC-/-, NLRP3-/-, and 
AIM2-/- mice. The C57BL/6, TLR3-/-, TLR2/9-/-, and STINGgt/gt mice were kept in the 
animal facility of The Faculty of Health, Aarhus University, while the ASC-/-, NLRP3-/-, 
and AIM2-/- mice were kept in the animal facility of UMASS Medical School, MA, USA. 
All mice were housed in a specific pathogen-free environment.
Viruses
MHV68 used in this study was the WUMS strain. MHV68 was propagated and titrated in 
BHK-21 hamster kidney cells in Glasgow modified essential medium (G-MEM). For select 
experiments we used BAC-derived MHV68-GFP (20). The ORF64 C33A mutant and the 
ORF36 N36S mutant, we well as the corresponding revertant viruses were produced as 
previously described (21,22). KSHV was produced as described previously (9). Briefly, 
baculovirus ORF50 was amplified in Sf9 cells. Vero cells stably expressing KSHV-GFP 
were infected with baculovirus ORF50 and treated with 2 mM sodium butyrate to allow 
reactivation of the latent KSHV. At 72 h supernatant was harvested and filtered through a 
sterile 0.45μM filter. Virus concentration was performed by layering virus supernatant over 
a cushion of 20% sucrose. The virus was pelleted by ultracentrifugation for 2 h at 4°C at 
24,000 rpm. Virus pellets were resuspended in endotoxin-free sterile DPBS.
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Herpes simplex virus 1 (HSV-1, KOS strain) and the VP1-2 C65A mutant (23) was 
amplified in Vero-cells. MCMV mutagenesis, diagnosis, and propagation were performed 
essentially as previously described (24). MCMV-K181 bacterial artificial chromosome 
(accession AM886412.1; (25)) was used to generate MCMV-M48(C23S) by recombineering 
using a two-step allelic exchange. Briefly, a selection/counter-selection cassette was used to 
replace nucleotides 67098-67111 of the WT MCMV BAC, which was in turn replaced with 
a PCR amplicon containing synonymous substitutions to introduce a unique diagnostic 
restriction site and a T to A substitution mutation at genomic position 67109, changing 
codon 23 of M48 from cysteine (TGC) to serine (AGC). Recombinant BACs were selected 
and confirmed by PCR and RFLP analysis. Infectious virus was reconstituted as previously 
described (24), amplified by growth in STO cells (CRL 1503; ATCC, USA) in the presence 
of 25 μg/ml 6-thioguanine (Sigma, USA), and plaque purified by limiting dilution. Parental 
and mutant viral stocks were then generated as previously described (24) in NIH3T3 
fibroblasts or IFNAR1-/- MEFs. Virus preparations were tested for endotoxin content, and 
found all to contain similar low levels (∼ 0.75 endotoxin units/ml).
Reagents
For in vitro stimulation experiments we used dsDNA (HSV60mer, 2 μg/ml), cGAMP (2 μM) 
(InvivoGen), Poly (I:C) (25 μg/ml) (InvivoGen), ODN1826 (5 μM) (InvivoGen), 
Pam3CSK4 (200 ng/ml)(InvivoGen), Lipopolysaccharide (200 ng/ml) Poly (dA:dT) (1 
μg/ml) (Sigma-Aldrich), Nigericin (10 μM) (Sigma-Aldrich), recombinant murine IFN-β and 
TNF-α (both R&D Systems). The HSV-1 60mer is derived from the HSV-1 genome nt. 
144107-144166 and was obtained from DNA Technology (26). For transfection, the DNA 
was complexes with lipofectamin2000 (Invitrogen) and transfected into the cells according 
to manufacturer's instructions.
Primary murine bone-marrow-derived cells
Bone marrow cells were harvested from the hind legs of mice. Cells were cultured in growth 
media (RPMI-1640 medium with 10 % heat-inactivated fetal calf serum (FCS), 600 μg/ml 
Glutamine, 200 IU/ml of penicillin and 100 μg/ml streptomycin (Gibco)) and stimulated 
with GM-CSF (R&D Systems) in the concentration of 40 ng/ml. On day 3 and day 5 fresh 
GM-CSF was added. On day 7 the non-adherent bone-marrow derived dendritic cells 
(BMDC), and the adherent cells bone marrow derived macrophages (BMMs) were 
harvested. For experiments, cells were seeded out in RPMI-1640 medium with 10 % FCS at 
a density of 200.000 cells per cm2.
Human monocyte/macrophage cell line
THP1 cells (ATCC) were cultured as non-adherent monocyte like cells in growth media 
(RPMI containing 10% FCS, 600 μg/ml Glutamine, 200 IU/ml of penicillin and 100 μg/ml 
streptomycin (Gibco)). The cells were differentiated into macrophage-like cells by addition 
of 150 nM Phorbol 12-myristate 13-acetate (PMA) (Sigma-Aldrich) 16-20 h prior to use in 
experiments.
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shRNA mediated silencing
The lentiviral shRNA expression plasmid pLKO.1 was utilised for generating stable gene 
expression knockdown in THP1 cells (OpenBiosystems, Huntsville, AL). The targeting 
shRNA sequence was: IFI16 clone ID # TCRN0000019079; Sting clone ID # 
TCRN000163296 and AIM2 clone ID # TRCN0000107503. The control shRNA vector was 
an empty vector pLKO.1 with an 18nt shuttle sequence instead of the hairpin sequences. 
Virus-like particles were produced using Fugene 6 (Roche) transfection of HEK293T cells 
with the packaging system pMDIg/p-RRE, pRSV-rev, pMG.2 and shRNA vector plasmid. 
Virus supernatants were harvested after 48 hours and filtrated through a 0.45um membrane. 
Undifferentiated THP1 cells were infected with increasing amounts of virus supernatant and 
after two days post infection placed under selection with puromycin at 1ug/ml. Levels of 
knockdown on IFI16 and STING were determined by Western blotting on extracts from 
differentiated THP1 as described (27). For detection of AIM2 we used anti-human AIM2 
(Adipogen, clone 3B10) and anti-β-Actin.
Murine intranasal MHV68 infection model
Mice were infected intranasally with 5×104 pfu of MHV68 in 25 μl while under anesthesia. 
On day 3, 6, 16 or 90 post infection, the mice were euthanized by cervical dislocation, and 
use for further analysis.
Isolation of single cells from the lung
The lung was removed and followed by an injection of 1 ml digestion media (Collagenase/
Dispase 1 mg/ml DNAse 0.5 mg/ml in PBS) into the tissue. The lung was subsequently 
digested in a digestion media in 10% FCS in IMEM at the concentration mentioned above 
for 30 minutes in 37°C incubator. Single cells of the lungs were obtained by grinding the 
tissues passing through the strainer 70 μm. The cell suspension was incubated with ACK 
lysis buffer for 3 minutes to eliminate the red blood cells, washed and supernatant was 
discarded. Single cells were resuspended in 0.5% BSA/PBS for subsequent analysis.
Flow cytometry analysis
Single cells were blocked with Fc blocking antibody (2.4G2), and subsequently stained with 
the following antibodies: CD11b (M1/70), Ly6g (1A8), CD3 (17A2), CD19 (1D3), I-Ab 
(AF6-120.1) and CD11c (HL3) from BD: CD4(GK1.5) and CD8a (53-6.7) from 
eBioscience: F4/80 (Cl:A3-1) from Serotec. Dead cells were excluded by staining with Aqua 
(Invitrogen). Data were collected with a FC500 instrument (Beckman Coulter) and were 
analyzed using FlowJo software (Tree Star).
Gene expression analysis by nCounter (Nanostring)
RNA isolated from cells that were mock infected or infected with MCMV and MHV68 as 
indicated. Cells were harvested into RLT buffer containing 2-βME for subsequent 
processing with the RNeasy Mini kit (Qiagen). Each RNA sample was adjusted to contain 
the same quantity by using the Nanodrop ND-1000 spectrophotometer (Thermo Scientific). 
RNA was then hybridized and quantified with the NanoString nCounter analysis system 
(NanoString Technologies, Seattle, WA) using a customized probeset containing probes for 
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innate immune genes per the manufacturer's protocol. The gene expression data were first 
normalized to an internal positive control, then to an internal negative control and finally to 
seven housekeeping genes, (GAPDH, β-glucuronidase, β-actin, hypoxanthine 
phosphoribosyltransferase 1, tubulin β, phosphoglycerate kinase 1, and clathrin H chain 1). 
All values were log10-transformed and a heat map was generated using the open source R-
based software at UMMS.
ELISA
Supernatants or spleen homogenates from cells cultures and mice, respectively, were 
analyzed for cytokine levels by ELISAs for human IL-1β and the murine cytokines IL-1β, 
CXCL10, TNF-α, IFN-γ, or IL-6 using matched antibody pairs obtained R&D Systems, as 
described previously (17,28).
Type I IFN Bioassay
IFN-α/β levels were measured by a cell based assay. In brief supernatant harvested from 
BMDCs or BMMs was UV-treated for 6 minutes to inactivate residual virus in the samples. 
Afterwards, samples were plated in successive 2-fold dilutions on a 96-well plate, with 
20.000 L929-cells per well in 100 μl MEM with 5 % FCS. After overnight incubation, the 
L929 cells were infected with vesicular stomatitis virus (VSV/V10). After 2-3 days of 
infection, the results were evaluated by microscopic examination of each well. A 50 % 
protection of cells in a well from virus-induced cell death was used defined as 1 U/ml of 
IFN- α/β.
Quantitative real-time polymerase chain reaction (PCR) analysis
RNA was purified from homogenates of lung tissues using RNeasy Plus Mini Kit (Qiagen) 
following the manufacturer protocol. The RNA was treated with DNase I to eliminate 
contaminating genomic DNA. RNA was isolated from cells in culture using High Pure RNA 
Isolation Kit (Roche). Expression or mRNAs for human and murine cytokines was 
determined by real time PCR, using TaqMan detection systems (Applied Biosystems). 
Expression levels were normalized to β-Actin expression and data presented as the fold 
induction over un-treated controls for each phenotype. The TaqMan assays used were: 
hIFN-β, Hs01077958_s1; hTNF-α, Hs01113624_g1; hβ-Actin Hs99999903_m1; mIFN-β, 
Mm00439546_s1; mCXCL10, Mm00445235_m1; mβ-actin, Mm01205647_g1. For 
detection of viral genomic material, DNA was isolated from lungs and spleens using 
ISOLATE II Genomic DNA Kit (Bioline). For amplification of MHV68 glycoprotein B 
DNA we used the primers: Forward: 5′-CCGCTCATTACGGCCCAAATTCAA-3′; 5′-
Reverse: GGCAGCGACAGGCTTTCCATAAAT-3′. SYBR green was used a fluorescent 
dye to quantitate DNA products in real time.
Confocal microscopy
For visualization of IFI16 and STING, following infection, THP1-cells were fixed and 
permeabilized with methanol at -20°C and labeled with antibodies against IFI16 (N-terminal 
Santa Cruz sc-8023) or STING (Imgenex IMG-6485A). Images were acquired on Zeiss 
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LSM 710 confocal microscope, using 63× 1.4 oil lense. Image processing was performed 
using Zen 2010 (Zeiss) and ImageJ.
Propagation of deoxy-5-ethynylcytidine (EdC)-labeled MHV68 and visualization of capsid-
free DNA
EdC (deoxy-5-ethynylcytidine) labeled MHV68 was propagated in BHK-21 cells in 
presence of 3 uM EdC (Sigma, St. Louis), which was added at 6 hours post infection. The 
supernatant was collected 4 days later, and debris was removed by centrifugation at 4500× g 
for 1 hour. Virus in the supernatant was pelleted at 26700× g for 5 hours and resuspended in 
PBS, followed by determination of the viral titers on BHK-1 cells. To visualize capsid-free 
viral DNA in the infected cells the Click-iT Imaging Kit (Invitrogen, Carlsbad) was used. 
Briefly, the infected cells were fixed with methanol for 5 min at -20 °C, and stained with 
click staining mix, freshly prepared according to the manufacture, at room temperature for 
30 min in the dark. Nucleoli of the cells were stained with DAPI. Images were acquired on a 
Zeiss LSM 710 confocal microscope, using a 63× 1.4 oil-immersion objective; Image 
processing was performed using Zen 2010 (Zeiss).
Statistics
The data are shown as mean ± st.dev. Statistically significant difference between 
observations was determined by 2-tailed Student's t test or Wilcoxon rank sum test. For p 
values of less than 0.05, data were considered to be significantly different.
Ethics
Protocols for the animal experiments were approved by the Local Ethical committees and 
conducted in accordance with institutional guidelines for animal care and use.
Results
Induction of innate immune responses by alpha-, beta-, and gamma-herpesviruses in 
leukocytes
In a first series of experiments we wanted to characterize the ability of MHV68 to induce 
cytokines associated with innate immune responses and compare with MCMV and HSV-1. 
BMDC were seeded and infected with increasing doses of MHV68, HSV-1 and MCMV. 
The doses of MCMV and HSV-1 were chosen based on experiments where CXCL10 
induction by different doses of these viruses were examined (Supplemental Fig. 1A). 
Despite clear induction of type I IFN expression by MCMV and HSV-1 infections, we were 
not able to detect IFN bioactivity in the supernatants from cells infected with MHV68 (Fig. 
1A). This was not due to lack of infection of the cells as measured by expression of GFP in 
cells infected with an MHV68-GFP virus (Supplemental Fig. 1B). By contrast to the lack of 
type I IFN induction, MHV68 infection in DCs did stimulate expression of TNF-α, IL-6 and 
IL1β, although high doses of virus were required to evoke these responses (Fig. 1B-1D). A 
similar picture was observed in BMMs with no detectable IFN bioactivity in the 
supernatants from MHV68-infected cells but clear induction of IL-6 and TNF-α and modest 
induction of IL-1β (Supplemental Fig. 1C-1F).
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To get a more complete picture of the innate response evoked by MHV68 infection in DCs, 
we subjected RNA isolated from mock or virus infected cells to analysis using nCounter 
(Nanostring), a fluorescent barcoded technique that allows multiplex analysis of mRNA's 
important in innate immunity. Infection with MHV68 did stimulate expression of most 
mRNAs transcripts examined for (Fig. 1E). However, the response to MHV68 infection was 
generally much lower than what was induced by MCMV infection. In particular, transcripts 
for type I IFNs (IFN-β and IFN-α4) and IFN-stimulated genes (ISGs) accumulated at much 
lower levels in cells infected with MHV68 as compared to infection with MCMV. 
Consistent with this, we found induction of the ISG CXCL10 at the protein level only after 
MHV68 infection at high MOI (Supplemental Fig. 1G).
Altogether, infection of macrophages and DCs with the gammaherpesvirus MHV68 induced 
expression of genes associated with innate immunity to a limited extent compared to what 
was observed after infection with other classes of herpesviruses. In particular, the IFN 
response to MHV68 infection was weak indicating this virus possesses immune evasion 
strategies targeting the IFN pathway.
Role for TLRs and DNA sensing pathways in the innate immune response to 
herpesviruses in dendritic cells
In order to characterize the pathways through which herpesviruses induced innate immune 
responses, we first examined whether lack of STING expression affected activation of innate 
immune responses by MHV68. For comparison, we included alpha- and beta-herpesviruses 
in the analysis. As expected, induction of type I IFN bioactivity by HSV-1 and MCMV was 
strongly reduced in cells from STINGgt/gt mice (Fig. 2Ai-Bi), whereas the IL-1β response 
was unaffected (Fig. 2Aii-Bii). In addition, the induction of TNF-α and IL-6 by the alpha- 
and beta-herpesviruses was significantly impaired in BMDCs lacking STING (Fig. 
2Aiii-2Aiv, 2Biii-2Biv), clearly demonstrating an essential role for STING in immune 
activation beyond the IFN pathway. In sharp contrast to the strong dependence on STING 
for induction of innate immune responses by HSV-1 and MCMV, we found that the ability 
of MHV68 to evoke expression of TNF-α and IL-6 was not affected by the absence of 
STING (Fig. 2C), but was significantly compromised in cells from TLR2/9-/- mice 
(Supplemental Fig. 2A-2D). As controls we measured cytokine levels in supernatants from 
BMDCs treated with synthetic dsDNA or poly I:C. These data confirmed an essential role 
for STING in DNA-induced expression of type I IFNs, IL-6 and TNF-α, but not IL-1β (Fig. 
2D), and that RNA-induced innate immune responses occur independent of STING (Fig. 
2E). Collectively, these data show that MHV68 stimulates expression of inflammatory 
cytokines in myeloid cells in a manner independent of STING but dependent on TLRs.
In a next series of experiments we challenged mice intranasally with MHV68 and examined 
viral load in the lungs during the acute phase of the infection (day 3 and 6) and in the spleen 
during latency (day 16 and 90). Interestingly, we observed elevated levels of viral DNA in 
the lungs of STINGgt/gt mice on day 3 post infection (Fig. 2F). However, this difference did 
not reach statistical significance on day 6 post infection (Fig. 2G), and on day 16 and 90, no 
significant difference in splenic latent viral load was observed between C57BL/6 and 
STINGgt/gt mice (Fig. 2H, 2I). In corroboration with this, the STING-deficient mice 
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exhibited an early weight loss after MHV68 infection, which was not seen in wild type mice, 
but at later time points the two mice strains followed indistinguishable weight curves (Fig. 
2J). A flow cytometric characterization of spleen cells from C57BL/6 and STINGgt/gt mice 
revealed no significant difference in the number of B cells between the two strains (Table 1). 
B cells are required for establishment of latency after intranasal MHV68 infection (29). 
However, we did observe that several leukocytes cell types were suppressed in STINGgt/gt 
but not C56BL/6 mice infected with MHV68 for 90 days (Table 1). For TLR2/9-/- mice, we 
also observed elevated viral load in the lungs on day 3, but not on day 90 in the spleen 
(Supplemental Fig. 2E-2F). Despite the early STING-dependent control of MHV68 in the 
lungs, we did not find elevated expression of IFN-β mRNA in the lungs of infected mice 
(Fig. 2K). By performing a wider screen for MHV68-induced gene expression in the lungs, 
CXCL10 was the only mRNA found to be elevated in the lungs after infection, and this was 
dependent on expression of STING (Fig. 2L). This correlated with early recruitment of 
macrophages to the lungs through a STING-dependent process (Fig. 2M). Thus, STING 
plays a limited role in activation of the pathways mediating control of MHV68, which failed 
to induce type I IFN responses in vitro and in vivo. However, we did observe a very early 
role for STING in vivo correlating with low induction of CXCL10 and recruitment of 
macrophages.
The finding that MHV68-induced cytokine expression occurred independent of STING 
indicated that this virus, in contrast to alpha- and beta-herpesviruses, triggers innate immune 
responses independent of intracellular DNA sensing. Another major pathway of DNA-
driven innate immune activation is the AIM2 inflammasome pathway. Therefore, we 
examined the role for AIM2 in production of IL-1β in lipopolysaccharide -primed BMMs. 
We first showed that these cells did produce high amounts of IL-1β in response to the potent 
inflammasome activator poly(dAdT) and this was dependent on AIM2 and the 
inflammasome adaptor protein ASC, but not NLRP3 (Fig. 3A). For MCMV, production of 
IL-1β was strongly reduced in AIM2-/- and ASC-/- cells as previously reported (4) (Fig. 3A). 
By contrast, MHV68 induced IL-1β secretion in a manner independent of AIM2 but 
dependent on NLRP3 and ASC (Fig. 3B). The AIM2 independent nature of the MHV68-
driven response was also observed in vivo, since AIM2 deficiency did not reduce the levels 
of IL-1β or IFN-γ, the latter produced through an IL-18 dependent pathway (4), in mice 
infected with MHV68 (Fig. 3C, 3D). In further support of the lack of a role for AIM2 in 
immune sensing of MHV68, AIM2-deficiency did not affect viral load in mice latently 
infected with MHV68 (Fig. 3E). By contrast, ASC-/- and NLRP3-/- mice exhibited 
significantly elevated viral load, demonstrating that the inflammasome was involved in 
control of MHV68 infection (Fig. 3E). Collectively, these data demonstrate that MHV68 
activates the inflammasome pathway via the NLRP3-ASC pathway and independent of the 
DNA-sensing AIM2 inflammasome.
KSHV induces innate immune responses independent of known DNA-stimulated pathways
KSHV is a human gammaherpesvirus closely related to MHV68 and the cause of Kaposi's 
Sarcoma (30). In order to determine whether KSHV also stimulates innate immune 
responses independent of known intracellular sensing systems, we first examined the effect 
of STING knock-down on virus-induced cytokine expression. The STING shRNA knock-
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down cell line has been reported previously (27), and was tested to have more than 80 % 
reduced expression of STING as compared to the empty vector control cell line. As shown 
in Fig. 4A and 4B, knock-down of STING in THP1 cells reduced expression of IFN-β and 
TNF-α induced by HSV-1 or dsDNA but did not affect the cytokine response to KSHV. 
This was not due to inability of KSHV to infect the cells as evidenced by green fluorescence 
in cells infected with a GFP-encoding KSHV (Supplemental Fig. 3). Consistent with a 
limited role for STING in the response to KSHV, we found that in contrast to what was 
observed after HCMV infection, neither STING nor IFI16, were mobilized after infection 
with this virus (Fig. 4C). To test the role for AIM2 in KSHV-induced IL-1β expression, we 
generated a stable THP1 cell with shRNA-mediated knock-down of AIM2 (Fig. 4D). 
However, despite efficient knock-down of AIM2, the ability of KSHV to induce IL-1β 
production was not affected. It has been reported that KSHV activates an IFI16-dependent 
inflammasome after nuclear sensing of the virus in endothelial cells(14). To test the role for 
IFI16 in IL-1β production during KSHV infection, we measured IL-1β levels in supernatants 
from THP1 cells expressing control shRNA or IFI16 shRNA. The IFI16 shRNA knock-
down cell line cell line has been reported previously (27), and was tested to have more than 
80 % reduced expression of IFI16 as compared to the empty vector control cell line. In 
contrast to the previous data from endothelial cells, we did not observe reduced KSHV-
induced IL-1β expression in monocytic cells with IFI16 knock-down (Fig. 4E). We also 
found that the induction of IFN-β by KSHV was independent of IFI16, in contrast to HSV-1, 
which relied on this DNA sensor for stimulation of IFN-β expression as previously reported 
(17). All together, these data show that KSHV, like MHV68, stimulates innate immune 
responses independent of the DNA-driven pathways via STING and AIM2.
The MHV68 ORF64 DUB antagonizes innate immune responses activated by viral DNA
Given the finding that MHV68 infection in myeloid cells did not lead to detectable innate 
immune activation by the DNA-sensing pathway, we were interested in identifying the step 
in the pathway targeted by the virus. In a first series of experiments, we pretreated murine 
DCs with MHV68 followed by infections and stimulations as indicated in Fig. 5A. 
Supernatants were collected for measurement of type I IFN activity. Interestingly, we 
observed that HSV-1-induced expression of type I IFN, CXCL10 and IL-6 was abrogated in 
cells pretreated with MHV68 (Fig. 5A, Supplemental Fig. 4A-4B). By contrast, MHV68 
infection did not affect the ability to activate the pathway via dsDNA or cGAMP, nor was 
the virus able to modulate the intracellular RNA sensing pathway. The inhibition of HSV-
induced cytokine expression by MHV68 was not due to a blockage of HSV-1 entry, since 
accumulation of the HSV major capsid protein VP5 in the cytoplasm of infected cells was 
not affected by pretreatment with MHV68 (Supplemental Fig. 4C). Similar to the inhibition 
of HSV-1-induced IFN expression, MHV68 also inhibited IL-1β expression induced by 
MCMV but not synthetic DNA (Fig. 5B). Upon examination of the assembly of STING 
signalsomes, as measured by STING foci formation and recruitment of TBK1, we found that 
although HSV-1 infection did stimulate this activity, MHV68 infection did not (Fig. 5C). 
Despite the lack of response to MHV68 infection, purified MHV68 DNA did induce IFN-β 
expression if transfected into cells (Fig. 5D). These findings suggest that MHV68 infection 
inhibits herpesvirus-driven DNA-mediated immune activation and suggests that this occurs 
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upstream of the bifurcation into the STING-dependent IFN pathway and the AIM2-
dependent IL-1β pathway.
The findings above indicate that gammaherpesviruses target a step general for all virus-
activated DNA-dependent innate pathways tested. We recently reported that alpha- and beta-
herpesvirus capsids become ubiquitinated and degraded in the cytoplasm in macrophages, 
hence exposing the viral DNA for cytosolic DNA sensors (17). Since herpesviruses encode a 
conserved DUB activity embedded in the large tegument protein (21,31,32), we 
hypothesized that herpesviruses utilize this activity to counteract DNA-driven innate 
immune activation. To address this question, DCs were stimulated with a MHV68 mutant 
with a point mutation in the active site of the DUB as well as with a revertant virus (21). 
Interestingly, in contrast to the revertant virus, infection with the DUB active site mutant 
virus did stimulate type IFN activity and led to elevated IL-1β production (Fig. 5E and 5F). 
The IFN response was dependent on STING, thus demonstrating that deletion of the DUB 
activity of ORF64 exposes an intrinsic capacity of gammaherpesviruses to stimulate DNA-
driven innate immune responses (Fig. 5G). The MHV68 kinase ORF36, previously reported 
to inhibit IFN regulatory factor 3 activation in fibroblasts (22), did not seem to be essential 
for evasion of DNA-driven IFN expression in myeloid cells (Supplemental Fig. 4D). In 
order to evaluate whether infection with the ORF64 C33A mutant differed from WT virus 
with respect to subcellular localization of viral genomes, we generated MHV68 with EdC 
incorporated into the viral genomes. In infected cells the viral genomes were visualized 
using click-chemistry (33). Interestingly, while the viral genome was found mainly in the 
nucleus of cells infected with the revertant virus, the viral DNA was localized preferentially 
to the cytoplasm in cells infected with the ORF64 C33A virus (Fig. 5H, 5I).
In order to evaluate whether the DUB activity of alpha- and beta-herpesviruses also plays a 
role in immune evasion, DCs were infected with WT or DUB mutant HSV-1 and MCMV 
followed by measurement of IFN bioactivity in the culture supernatants. For both HSV-1 
and MCMV we found that although the WT viruses did induce IFN expression, this was 
further elevated in the absence of the tegument DUB activity (Fig. 5J and 5K). Together, 
these data demonstrate that deletion of the DUB activity of the large MHV68 tegument 
protein ORF64 leads to augmented cytosolic localization of viral DNA, and renders MHV68 
capable of stimulating DNA-driven innate immune responses. Moreover, the data also reveal 
the herpesvirus tegument DUB activity to be a conserved mechanism to counteract immune 
activation through the DNA-driven STING pathway.
ORF64 DUB deficiency enables a STING-dependent antiviral pathway controlling 
establishment of a latent MHV68 reservoir
Given the finding that the ORF64 DUB active site mutant gained the capacity to induce IFN 
expression in a STING-dependent manner, we were interested in examining whether this 
MHV68 mutant had an altered course of infection in wild type and STINGgt/gt mice. A 
previous report has shown that the MHV68 ORF64 C33A mutant was not attenuated with 
respect to the ability to establish latent infection after intraperitoneal infection (21). In this 
study we used the intranasal infection model, and it has previously been reported that the 
route of infection affects the role of innate immune pathways in control of MHV68 infection 
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(19). We first examined whether the MHV68 ORF64 DUB mutant was capable of inducing 
IFN-β expression in vivo and also whether treatment with recombinant IFN-β affected the 
acute viral load in the lungs and the latent viral reservoir in the spleen. As shown in Fig. 6A, 
RNA in lung homogenates from mice infected for 3 days with the MHV68 ORF64 C33A 
mutant contained elevated levels of IFN-β mRNA, whereas the IFN-β mRNA levels in 
homogenates from mice infected with the revertant virus were indistinguishable from the 
mock treated mice. This finding prompted us to evaluate whether an elevated innate immune 
response could affect viral load in infected organs at different time points during the 
infection. Therefore, mice were treated with recombinant IFN-β and TNF-α before the 
infection and subsequently once every week during the course of the infection. When 
evaluating the viral load in the lungs, we found that IFN-β treatment led to reduced 
accumulation of viral DNA on day 6 post infection (Fig. 6B). Interestingly, in the spleens 
harvested 90 day after infection, treatments with single cytokines had not affected the latent 
viral load, but this was indeed the case in spleens from mice treated with both IFN-β and 
TNF-α (Fig. 6C). Thus, the elevated expression of proteins associated with innate immune 
responses during infection with the MHV68 ORF64 DUB mutant could potentially affect 
viral load in the lung and the spleen.
In a final series of experiments, we challenged C57BL/6 and STINGgt/gt mice with the 
MHV68 ORF64 C33A mutant or the revertant virus. When measuring viral load in the lung 
on day 3 post infection, significantly elevated levels of virus were found in STINGgt/gt mice 
as compared to wild type mice after infection with either virus (Fig. 6D). However, no 
significant difference between the viral loads in the lungs of mice infected with the DUB 
mutant or revertant viruses were observed, regardless of the mouse strain (Fig. 6D). Thus, 
lack of ORF64 DUB activity does not affect the early stages of MHV68 infection. By 
contrast, when we looked for viral DNA in the spleen from mice infected for 16 or 90 days, 
we observed significantly lower levels of viral DNA in C57BL/6 mice infected with the 
MHV68 ORF64 DUB mutant as compared to the revertant virus (Fig. 6E and 6F). 
Interestingly, the impaired ability of the MHV68 ORF64 DUB mutant to establish latent 
infection was rescued when the infection occurred in STINGgt/gt mice. Similar experiments 
in TLR2/9-/- mice revealed that the ORF64 DUB mutation did not confer mouse-genetics-
dependent differential latent viral load in this model (Supplemental Fig. 2G, 2H). 
Altogether, MHV68 antagonizes the STING-dependent pathway stimulated by viral 
genomic DNA through a mechanism dependent on the DUB embedded in ORF64, and this 
facilitates establishment of a latent reservoir of MHV68.
Discussion
KSHV and EBV are important human pathogens, and are among the small group of viruses 
capable of causing tumors (30). These viruses belong to the family of gammaherpesviruses, 
and have the capacity to establish lifelong latent-recurrent infections. The ability of the host 
to control infections with herpesviruses is important for prevention of disease development, 
as exemplified by the frequent development of Kaposi's sarcoma in individuals with 
acquired immunodeficiency syndrome (30). It is now known that herpesviruses are 
controlled by both the innate and adaptive immune system, but despite this there is limited 
knowledge on how the innate immune system detects infections with gammaherpesviruses. 
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Recently much attention has been given to DNA as a major stimulator of innate immune 
responses (34), and it has been reported that alpha-herpesviruses (HSV), and beta-
herpesviruses (CMV) are detected by the DNA sensing machinery (4,10,17). At this stage, 
two major pathways of immune activation by DNA are known: DNA-induced IFN 
responses relying on the adaptor protein STING (2), and DNA-stimulated inflammasome 
activation occurring via AIM2 (16). Here we show that wild type MHV68 is a poor inducer 
of innate immune responses and the responses evoked by MHV68 and also by KSHV are 
independent of described intracellular DNA sensing systems known to be essential for host 
detection of alpha- and beta-herpesviruses. In line with this, STINGgt/gt and AIM2-/- mice 
did not exhibit major defects in control of MHV68 infection, and in particular the 
establishment of latent viral reservoirs was unaffected by defective DNA sensing pathways. 
An MHV68 mutant with a point mutation in the tegument DUB ORF64, which is conserved 
among herpesviruses, induced significant type I IFN expression through a STING-dependent 
mechanism. Moreover, wild type mice infected with the DUB mutant harbored a lower 
latent viral load than mice infected with the revertant, but this impaired activity of the DUB 
mutant was rescued in STINGgt/gt mice. Altogether, we propose that gammaherpesviruses 
target the DNA sensing system and this contributes to the ability of this class of viruses to 
establish latent infections.
In myeloid cells MHV68 did not stimulate detectable IFN bioactivity but did stimulate 
expression of IL-1β, IL-6 and TNF-α to significant levels. However, the IL-1β response was 
independent of AIM2, but dependent on NLRP3 and ASC, and the induction of TNF-α and 
IL-6 was dependent on TLR2 and TLR9. This was in contrast to the responses evoked by 
HSV-1 and MCMV where important roles were ascribed to STING and AIM2 for induction 
of type I IFN expression and secretion of IL-1β, respectively. Similar to what we found with 
MHV68 in murine myeloid cells, the induction of IFN-β and IL-1β evoked by KSHV 
infection in a human monocytic cell line, was independent of STING and AIM2. Thus, 
unlike alpha- and beta-herpesvirues, gammaherpesviruses are detected independent of the 
intracellular DNA sensing system, at least in the cell types tested, where particularly the 
TLR pathway is important for induction of inflammatory genes and also for early control of 
viral load in vivo. The role for TLRs in sensing of gammaherpesviruses is in line with 
previous work demonstrating that TLR2 and 9 can recognize gammaherpesviruses, with 
particularly the recognition by TLR9 in plasmacytoid DCs being well documented 
(9,18,19,35). For TLR2, a role has been reported in fibroblast and in early control in the lung 
after intranasal MHV68 infection (35). It should be noted that we did find elevated viral load 
in the lungs of STINGgt/gt mice at early time points after MHV68 infection correlating with 
weight loss and impaired recruitment of macrophages. At this stage, we cannot explain this 
early phenotype but possible explanations include (i) activation of DNA sensing in other cell 
types than the ones studied here, (ii) low grade sensing of MHV68 DNA and activation of 
signaling in the myeloid cells at early time points, and (iii) activation of STING-dependent 
signaling independent of DNA sensing, such as virus-cell fusion (28). A recent study 
demonstrated modest elevation of MHV68 load in lungs and spleen of cGAS-deficient mice 
on day 7 after intraperitoneal MHV68 infection (36). These results are consistent with our 
data, and suggest a minor role for the cGAS-STING pathway early during MHV68 infection 
despite the presence of ORF64.
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It has been reported that KSHV and EBV can be sensed by IFI16 in the nucleus to stimulate 
an IFI16-ASC-caspase 1 inflammasome in permissive and latently infected cells (14,37). In 
our system using a human monocytic cell line, we found that IFI16 was not essential for 
production of IL-1β during KSHV infection, indicating that this DNA sensor is not involved 
in KSHV-driven inflammasome activation in these cells. However, the data presented in this 
work do not address the question of where in the cell the DNA sensing takes place. 
Moreover, it is also important to note that the proposed nuclear IFI16-ASC-caspase 1 
inflammasome pathway is not abrogated in STINGgt/gt or AIM2-/- mice. Therefore, a 
potential role for nuclear DNA sensing during herpesvirus infections is not excluded by the 
data presented in this work.
The phenomenon of viral evasion of the innate immune response is well-described and 
known to impact the pathogenicity of viruses (38). Herpesviruses have been reported to 
target all steps in the pathway, including modulation of PAMPs (39), avoidance of 
sensing(40), inhibition of signaling (41), and inhibition of transcription of key genes, 
including IFN-β (5,42). Here we found that wild type MHV68 largely prevented expression 
of type I IFN expression in macrophages and myeloid DCs, and induced only modest levels 
of IL-1β. By contrast, in plasmacytoid dendritic cells and MEFs it has previously been 
shown that MHV68 induces type IFN expression and this is stimulated through TLR-
dependent pathways (19,35). Altogether, such data suggest that MHV68 utilizes cell-type 
specific means to evade innate immune responses and that ORF64 is of importance in cell 
types sensing this virus through the DNA sensing pathway. Other reported innate immune 
evasion mechanisms of MHV68 include targeting of TBK1 and IFN regulatory factor 3, by 
ORF11 and ORF36, respectively (22,43). As to the known roles of herpesvirus tegument 
DUBs in innate immune evasion, most information has been gathered through work in 
HEK293 cell-based systems. It has been reported that KSHV ORF64 can target RIG-I 
through deubiquitination of RIG-I (44), and that the EBV DUB BPLF1 inhibits the TLR2 
pathway by deubiquitination of TRAF6, NEMO, and IκBα(45). Using a similar system it 
has also been demonstrated that HSV-1 UL36 can target TRAF3 to prevent type I IFN 
expression through the RIG-I pathway (46). However, in contrast to the studies mentioned 
above, which were mainly performed in overexpression systems (44-46), we found no 
inhibitory effects of MHV68 infection on induction of type I IFN and IL-6 by Sendai virus 
and TLR ligands. Moreover, the MHV68 DUB mutant induced elevated expression of both 
type I IFN and IL-1β as compared to the wild type virus, and the IFN response was evoked 
through the DNA-stimulated STING pathway. Our data therefore do not support a model 
where the MHV68 DUB targets a specific TRAF protein during viral infection in myeloid 
cells, but rather that the virus targets a step at the level of DNA sensing upstream of 
bifurcation between the STING and AIM2 pathways. The herpesvirus DUB activity 
embedded in the N terminal part of the large tegument protein is highly conserved (31). 
Since this activity can cleave either K48- or K63-linked polyubiquitin chains it therefore 
seems likely that herpesvirus DUBs can serve a broad role in targeting of intracellular innate 
sensing and signaling pathways as already reported (44-46), and that this occurs in a manner 
dependent on a range of factors including cell types and the stage of the viral replication 
cycle.
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The establishment of latent gammaherpesvirus infections involves a complex series of 
events governed by viral proteins with a particularly important role for the latency-
associated nuclear antigen (47). In addition, several host systems are positively and 
negatively involved in establishment of latency, including IFNs, apoptosis, autophagy, and 
TLRs (47). We found that the DUB mutant virus, which activated STING-dependent innate 
immune responses, exhibited impaired ability to establish latent infection in the spleen. The 
mechanism mediating this STING-dependent restriction of latency was not identified in this 
study, and further work is needed to describe the pathway capable of controlling DUB-
deficient MHV68. Previous work has revealed that the route of viral infection impacts on the 
apparent role for specific proteins in the host response to MHV68 infection (19). The same 
may be the case for the ability of MHV68 to facilitate establishment of latency through 
targeting of the DNA sensing machinery. Published data on latent viral load in the spleen of 
C57BL/6 mice after intraperitoneal infection with the MHV68 ΔDUB mutants did not reveal 
an attenuated phenotype of the virus (21).
Collectively, in this work we report that gammaherpesviruses evade sensing of viral 
genomic DNA, which facilitates establishment of a latent viral reservoir in the host. These 
data are consistent with a role for the gammaherpesvirus DUB in prevention of innate 
immune activation by the viral DNA, and suggests the molecular target to be upstream of 
bifurcation into the AIM2 and STING pathways. The STING-dependent antiviral program 
impaired by ORF64 works together with TLR-mediated activities to control acute and latent 
MHV68 infection. We propose that the ability of gammaherpesviruses to deubiquitinate 
viral and cellular substrates plays an important role in viral immune evasion and hence for 
establishment of infection.
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Figure 1. 
MHV68 stimulates a blunted innate immune response in dendritic cells. (A-D) Mouse bone 
marrow-derived dendritic cells (BMDCs) from C57BL/6 mice were seeded and infected 
with MHV68 at increasing doses between MOI 1 and 1000 (in panel D between 10 and 
100), MCMV (MOI 1), and HSV-1 (MOI 3). Supernatants were harvested 24 hr post 
infection and used for measurement of cytokines by type I IFN bioassay (A) or ELISA (B-
D). Data are presented as means of measurements from triplicate cultures +/- st.dev. (E) 
BMDCs were treated with MCMV (MOI 10) and MHV68 (MOI 10) for 6 h, prior to harvest 
of total RNA, which was subjected to analysis for specific transcripts using NanoString 
Technology. Data are presented as heat maps. Arrows indicate type I IFN genes, while stars 
indicate IFN-stimulated genes. Data are representative of three independent experiments.
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Figure 2. 
A limited role for STING in host control of MHV68 infection. (A-E) BMDCs from 
C57BL/6 and STINGgt/gt mice were treated with (A) HSV-1, MOI 3, (B) MCMV, MOI 3, 
(C) MHV68, MOI 100, (D) dsDNA, 2 μg/ml, (E) Poly I:C. Supertantants were harvested 18 
h post treatment for measurement of levels of (row i) type I IFN bioactivity, (row ii) IL-1β, 
(row iii) TNF-α, (row iv) IL-6. Data are presented as means of measurements from triplicate 
cultures +/- st.dev. Data presented in panel A-E are representative of three independent 
experiments. (F-I) C57BL/6 and STINGgt/gt mice were infected intranasally with 5×104 pfu 
of MHV68. Lungswere isolated from mice infected for (F) 3 or (G) 6 days and spleens were 
isolated from mice infected for (H) 16 or (I) 90 days. Organs were homogenized and 
analyzed for the presence of MHV68 DNA by PCR. Each data point presented represents 
one individual mouse. (J) Weights of C57BL/6 and STINGgt/gt mice infected with MHV68. 
Data are presented as the mean weight of each group of animals +/- st.dev. Statistically 
significant difference between C57BL/6 and STINGgt/gt mice on day 6 is indicated with a 
star and the specific p value is given. (K-L) RNA was isolated from lung homogenates from 
C57BL/6 and STINGgt/gt mice (5 mice per group) 3 days after intranasal treatment with PBS 
or MHV68 (5×104 pfu). The RNA was analyzed for levels of IFN-β and CXCL10 mRNA by 
RT-qPCR. Data are presented as means +/- st.dev. (M) Single cell suspensions from lungs of 
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C57BL/6 and STINGgt/gt mice (5 mice per group) treated for 3 days as in panel J and K, and 
analyzed by flow cytometry for levels of macrophages using CD45+ autofluorescence+ 
CD11blow CD11c+ as markers. The data are presented as average number of alveolar 
macrophages per mouse +/- st.dev.
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Figure 3. 
The AIM2 inflammasome is not involved in immune activation during MHV68 infection. 
(A-B) BMMs from C57BL/6, ASC-/-, NLRP3-/-, and AIM2-/- mice were stimulated with 
lipopolysaccharide (200 ng/ml) for 3 h prior to treatment with MCMV (MOI 10), Poly 
dA:dT (1 μg/ml), nigericin (10 μM) or MHV68 (MOI 10). Supertantants were harvested 24 
h post treatment for measurement of IL-1β. Data are presented as means of measurements 
from triplicate cultures +/- st.dev. (C-E) C57BL/6 and AIM2-/- mice were infected with 
5×105 pfu of MHV68. Spleens were isolated from mice infected for 6 and 60 days. The 
organs were homogenized and analyzed for levels of IL-1β and IFN-γ by ELISA (day 6), 
and MHV68 DNA by PCR (day 60). (C, D) The ELISA data are presented as means of 
measurements from 6-8 mice per group +/- st.dev. (E) Each data point presented represents 
measurement of MHV68 DNA from one individual mouse. Data are representative of three 
independent experiments.
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Figure 4. 
KSHV induces expression of IFN-β and production of IL-1β independent of the STING and 
AIM2 pathways. (A-B) PMA-differentiated THP1-derived cells stably transduced with 
lentiviral shRNAs (control and STING) were infected with HSV-1 (MOI 3) or KSHV (30 
genomes/cell) or transfected with dsDNA (2 μg/ml). Total RNA was harvested 6 h post 
treatment and analyzed for levels of IFN-β and TNF-α. Data are presented as means of 
normalized ratios relative to untreated using β-actin as internal reference +/- st.dev. (C) 
MDMs were infected with CMV (MOI 3) or KSHV (30 genomes/cell) for 4 h. Subcellular 
distribution of IFI16 and STING was determined by confocal microscopy. White box 
indicates area displayed in zoom column (zoom is magnified 5× from original image). Scale 
bar, 10 μm. (D) Western blot of AIM2 and β-actin on extracts from PMA-differentiated 
THP1-derived cells stably transduced with lentiviral shRNAs (control and AIM2). The 
shRNA THP1 cells were left untreated or infected with KSHV. Supernatants were harvested 
18 h post and levels of IL-1β were measured by ELISA. Data are presented as means of 
normalized ratios relative to untreated +/- st.dev. (E-F) PMA-differentiated THP1-derived 
cells stably transduced with lentiviral shRNAs (control and IFI16) were infected with 
HSV-1 (MOI 3) or KSHV (30 genomes/cell). Total RNA and culture supernatants were 
harvested 6 h and 18 h post treatment, respectively and analyzed for levels of IFN-β mRNA 
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and IL-1β protein. Data are presented as means of normalized ratios relative to untreated +/- 
st.dev. All data presented in this figure are representative of four or more independent 
experiments. NR, normalized ratio.
Sun et al. Page 24
J Immunol. Author manuscript; available in PMC 2016 February 15.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 5. 
The DUB activity of MHV68 mediates evasion of herpesvirus-induced production of type I 
IFN and IL-1β. (A-B) BMDCs from C57BL/6 mice were infectedwith MHV68 (MOI 10) 1 
hour prior to treatment with HSV-1 (MOI 3), MCMV (MOI 1), ODN1826 (1 μM), poly I:C 
(25 μg/ml), dsDNA (2 μg/ml), cGAMP (2 μM), and lipofectamine. Supernatants were 
harvested 16 h later for measurement of type I IFN bioactivity and IL-1β. (C) BMDCs from 
C57BL/6 mice were infected with HSV-1 (MOI 3) and MHV68 (MOI 20) for 5 h and 
stained with DAPI and anti-STING and anti-TBK1 antibodies. (D) BMDCs were stimulated 
with genomic DNA from HSV-1 and MHV68 (0.25 μg/ml). Supernatants were isolated 18 h 
post stimulation for measurement of IFN bioactivity. (E-F) BMDCs from C57BL/6 mice 
were treated with MHV68 ORF64 C33A or the revertant virus at MOIs of 1, 10 and 100. 
Supernatants were harvested 16 h later for measurement of type I IFN bioactivity and IL-1β 
(only MOI 10). (G) BMDCs from C57BL/6 and STINGgt/gt mice were infected with 
MHV68 ORF64 C33A or the revertant virus (MOI 50). Supernatants were harvested 18 h 
post infection and IFN bioactivity was measured. (H) BMMs were infected with EdC-
labeled MHV68 ORF64 C33A or the revertant virus (MOI 20) for 3 h and fixed. Accessible 
DNA was visualized using copper(I)-catalyzed Azide Alkyne Cyccoaddiotion staining. 
Nucleic acids were visualized using DAPI. Scale bar, 10 μm. (I) Quantification of cytosolic 
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MHV68 DNA versus total MHV68 genomes in BMMs infected for 3 h with EdC-labeled 
MHV68 ORF64 C33A or the revertant virus (MOI 10 and 20). (J-K) BMDCs from 
C57BL/6 and STINGgt/gt mice were infected with DUB active site mutants of (J) MCMV 
(MOI 1) and (K) HSV-1 (MOI 3). Supernatants were harvested 18 h post infection and IFN 
bioactivity was measured. All cytokine data are presented as means of measurements from 
triplicate cultures +/- st.dev. All data presented in this figure are representative of three or 
more independent experiments.
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Figure 6. 
The ORF64 DUB activity facilitates establishment of latency by targeting a STING-
dependent pathway. (A) RNA was isolated from lung homogenates from C57BL/6 mice (5 
mice per group) 3 days after intranasal treatment with PBS, MHV68 ORF64 C33A, or the 
revertant virus (5×104 pfu). The RNA was analyzed for levels of IFN-β mRNA by RT-qPCR 
and presented as a normalized ratio using β-actin as internal reference. Data are presented as 
means +/- st.dev. (B, C) C57BL/6 mice were treated intraperitoneally with recombinant 
IFN-β and TNF-α (2 μg of each cytokine), at the time of intranasal MHV68 infection (5×104 
pfu) and every 7 days during infection. (B) Lungs were isolated from mice infected for 6 
days and (C) spleens were isolated from mice infected for 90 days. Organs were 
homogenized and analyzed for the presence of MHV68 DNA by PCR. Each data point 
presented represents one individual mouse. (D-F) C57BL/6 and STINGgt/gt mice were 
infected intranasally with 5×104 pfu of MHV68 ORF64 C33A or the revertant virus. (D) 
Lungs were isolated from mice infected for 3 days and (E, F) spleens were isolated from 
mice infected for 16 and 90 days. Organs were homogenized and analyzed for the presence 
of MHV68 DNA by PCR. Each data point presented represents one individual mouse.
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